CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2004-12-15): PET/CT improves detection of metastatic colorectal cancer

Clinical

PET/CT improves detection of metastatic colorectal cancer

Last Updated: 2004-12-15 14:05:30 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Simultaneous imaging with positron emission tomography (PET) and computed tomography (CT) is more sensitive than contrast-enhanced CT (ceCT) alone in the evaluation of patients for metastatic colorectal cancer, physicians in Switzerland report.

In fact, a change of therapy results for approximately one in five patients when PET/CT is used instead of ceCT, Dr. Pierre-Alain Clavien and his team at University Hospital in Zurich report in the December Annals of Surgery.

As they point out, the tumor load is often underestimated in patients with metastatic colorectal cancer. The researchers therefore devised "a new technique combining the same imaging session data of a full-ring PET-scanner with a multi-detector row helical CT." In the procedure "PET-positive lesions are projected directly into the CT scan to obtain simultaneous functional and anatomic information."

They prospectively assessed the use of ceCT and this new PET/CT technique in 76 colorectal cancer patients evaluated for resection of liver metastases. The findings were verified based on intraoperative findings and follow-up with serial ceCT.

The authors observed no difference between the two modalities regarding primary intrahepatic metastases

However, PET/CT identified local recurrence at the site of the primary tumor in 15 patients, versus the 9 identified by ceCT (sensitivity 93% versus 53%).

Extrahepatic metastases were identified in 34 patients with PET/CT and 24 with ceCT (sensitivity 89% versus 64%).

Overall, PET/CT changed the therapeutic strategy in 16 patients (21%). Ten patients considered resectable by ceCT were found to have extensive extrahepatic disease, representing a contraindication for surgery. Six patients underwent liver resection and removal of the peri-portal nodes based on PET/CT findings that were missed by ceCT.

Because intrahepatic vascular structures are poorly delineated with PET/CT, the research team now uses intravenous contrast when evaluating these patients.

"This may obviate the need for additional ceCT or magnetic resonance imaging, or perhaps colonoscopy. Such a strategy would be attractive, enabling a one-step diagnostic procedure," they conclude.

Ann Surg 2004;240:1027-1036.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.